StemSight | Curing Blindness With Stem Cells

Curing blindness through regenerative cell therapies. We replace what is lost.

StemSight develops off-the-shelf cell therapies to address unmet medical needs in corneal blindness.

We are the pioneers of combining iPS-derived cells with functional biomaterials. Our primary goal is to accelerate tissue regeneration, enhance the safety of cell therapies, and simplify cell delivery.

The most innovative startup in health and life sciences in Europe at BioFit, 2020

Award winner at TechTour’s flagship event, Europe’s Most Innovative Companies, 2022

Finalist at EIT Health Catapult Biotech pitching competition, 2022-2023

About us

The founding team of StemSight is comprised of top scientists in regenerative medicine and tissue engineering for eye applications. The scientific excellence is complemented by our distinguished board of accomplished industry leaders and advisors with extensive global business acumen.
READ MORE

Latest News

2025-09-25 00:00:00

StemSight welcomes Charlotta Backman as Head of Clinical Development

We are excited to welcome Charlotta Backman to StemSight as Head of Clinical Development. Charlotta brings her broad expertise on clinical development at the time when StemSight starts preparing for its transition from the pre-clinical setting to the clinic.

2025-09-03 00:00:00

StemSight and Mytos explore manufacturing collaboration for StemSight's lead product

Mytos, a biotechnology company automating cell manufacturing, StemSight and two other cell therapy developers announced collaborations aiming to increase the scalability and cost-efficiency of cell therapy manufacturing. The announcement was covered by Endpoint News.

2025-09-09 00:00:00

Anni Mörö steps down as StemSight's COO

StemSight's COO and co-founder Anni Mörö steps down from active role with StemSight due to personal reasons. Choosing to focus on her academic work and spending more time with her three daughters, she remains a firm supporter of StemSight's work - and we hope to welcome her back when the time is right.

2025-08-15 00:00:00

StemSight featured in Technology Networks

StemSight's CEO Laura Koivusalo interviewed by Blake Forman for Technology Networks article. The news piece nicely captures StemSight's groundbreaking work in aiming to cure blindness with stem cells.

More News

Latest blog post

StemSight Welcomes Charlotta Backman as Head of Clinical Development

Want to know more?

Interested to join our next investment round? Want to hear about our latest developments? Just thought of someone we absolutely need to meet?

Send us a message!

Subscribe to our newsletter

Subscribe now